Gracell Biotechnologies Inc.
Gracell Biotechnologies Inc. (GRCL) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · GRCL · as of Jun 9, 2026
Key Statistics
Explore Gracell Biotechnologies Inc. Data
grcl stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 8 · Buy rate: 37.5%
The GRCL analyst consensus is Hold, based on ratings from 8 Wall Street analysts over the past 3 months. The average 12-month price target is $6.00, representing -41.46% downside from the current price of $10.25.
Competitors & Peers
grcl competitorsGRCL
ALBO
CBIO
CMRX
EQRX
ETHZStock Performance
Full HistoryAbout Gracell Biotechnologies Inc.
Gracell Biotechnologies Inc. is a clinical-stage biopharmaceutical company focused on the discovery and advancement of cell-based therapies, primarily for cancer treatment, within the People's Republi…
what is gracell biotechnologies inc. · grcl stock overview · gracell biotechnologies inc. company profile · who is gracell biotechnologies inc. ceo · grcl NASDAQ · gracell biotechnologies inc. headquarters · gracell biotechnologies inc. business segments
About Stock Overview & Key Data
Gracell Biotechnologies Inc. (GRCL) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jan 8, 2021. As of the latest trading session, GRCL stock price is $10.25, with a market capitalization of $198.0M. The stock has returned +415.08% over the past 12 months and +1.49% year-to-date.
According to 8 Wall Street analysts, the consensus rating for Gracell Biotechnologies Inc. stock is Hold, with an average 12-month price target of $6.00. In fiscal year 2022, Gracell Biotechnologies Inc. reported revenue of — and net income of -$607.5M. For detailed data — including Gracell Biotechnologies Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Gracell Biotechnologies Inc. (GRCL) stock price is $10.25. The stock is traded on NASDAQ under the ticker symbol GRCL. The 52-week range is $1.40 – $10.44.